Product
Epoetin beta
1 clinical trial
3 indications
Indication
AnaemiaIndication
solid tumorIndication
Protocol SpecificClinical trial
Research Factors Predictive of Treatment Failure With Erythropoietin Beta (NeoRecormon®) in Patients With Solid Tumors Treated With ChemotherapyStatus: Terminated, Estimated PCD: 2011-12-31